Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Nov 15;56(22):3089-3092.
doi: 10.2169/internalmedicine.9037-17. Epub 2017 Sep 25.

"Brief" Aripiprazole-induced Neuroleptic Malignant Syndrome with Symptoms that Only Lasted a Few Hours

Affiliations
Case Reports

"Brief" Aripiprazole-induced Neuroleptic Malignant Syndrome with Symptoms that Only Lasted a Few Hours

Naoto Mizumura et al. Intern Med. .

Abstract

Neuroleptic malignant syndrome (NMS) with characteristic symptoms is a potentially lethal reaction to antipsychotic drugs. Atypical NMS usually lacks major symptoms and frequently occurs after treatment using atypical antipsychotics, such as aripiprazole. A 64-year-old man developed aripiprazole-induced NMS after surgery, and our early recognition of the NMS was based on high creatine kinase levels and low serum iron levels. His characteristic symptoms (a fever, rigidity, and altered mental status) were only present for a few hours and were resolved by aripiprazole discontinuation and supportive care. Aripiprazole-induced NMS can present with brief but major symptoms, and clinicians may overlook this "brief" appearance of NMS.

Keywords: antipsychotic agents; aripiprazole; early diagnosis; iron; neuroleptic malignant syndrome.

PubMed Disclaimer

Figures

Figure.
Figure.
Patient’s clinical course. *Blood pressure approximately equal to the baseline value. Urinary retention was not considered to be present because of the urethral catheter. SBP: systolic blood pressure, HR: heart rate, RR: respiratory rate, POD: postoperative day, WBC: white blood cell count, CK: creatine kinase

Similar articles

Cited by

References

    1. Gurrera RJ, Caroff SN, Cohen A, et al. . An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry 72: 1222-1228, 2011. - PubMed
    1. Picard LS, Lindsay S, Strawn JR, Kaneria RM, Patel NC, Keck PE Jr. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations. Pharmacotherapy 28: 530-535, 2008. - PubMed
    1. Belvederi Murri M, Guaglianone A, Bugliani M, et al. . Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R D 15: 45-62, 2015. - PMC - PubMed
    1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision. American Psychiatric Association, Ed. Medication-induced movement disorders: neuroleptic malignant syndrome. American Psychiatric Association, Washington, D.C., 2000: 795-798.
    1. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 142: 1137-1145, 1985. - PubMed

Publication types